GLP-1 Medications for Binge Eating Disorder
Binge eating disorder (BED) is the most common eating disorder in the US, characterized by recurrent episodes of eating large amounts of food in a short period with a sense of loss of control. GLP-1 medications reduce food noise and compulsive eating urges, providing neurological support for BED patients alongside behavioral therapy. Binge Eating Disorder affects approximately 2.8 million adults in the United States, and GLP-1 medications offer a clinically proven treatment option.
Prevalence
approximately 2.8 million adults in the United States
Recommended Medications
2
Treatment Type
GLP-1 Agonist
How GLP-1 Medications Help with Binge Eating Disorder
GLP-1 medications reduce food noise and compulsive eating urges, providing neurological support for BED patients alongside behavioral therapy. For patients with binge eating disorder, GLP-1 medications address the underlying metabolic dysfunction that makes weight management difficult. Clinical trials have consistently shown that GLP-1 treatment produces significant improvements in both weight and condition-specific outcomes.
Recommended GLP-1 Medications for Binge Eating Disorder
Based on clinical evidence, the following GLP-1 medications are recommended for patients with binge eating disorder:
Semaglutide
Wegovy / Ozempic
Tirzepatide
Zepbound / Mounjaro
Detailed Medication Guides for Binge Eating Disorder
Binge Eating Disorder & GLP-1 FAQ
Can GLP-1 medications help with binge eating disorder?
Yes. GLP-1 medications reduce food noise and compulsive eating urges, providing neurological support for BED patients alongside behavioral therapy. Clinical evidence supports the use of GLP-1 medications like semaglutide and tirzepatide for patients with binge eating disorder.
Which GLP-1 medication is best for binge eating disorder?
Semaglutide is often the first-line recommendation for binge eating disorder due to its strong clinical evidence. Your provider will evaluate your specific situation to determine the best option.
How much weight can I lose with GLP-1 if I have binge eating disorder?
Weight loss results are generally comparable to clinical trial averages (15-22% of body weight), though individual results vary based on the severity of binge eating disorder and other health factors.
How prevalent is binge eating disorder?
Binge Eating Disorder affects approximately 2.8 million adults in the United States. GLP-1 medications represent a significant treatment advancement for patients dealing with this condition alongside excess weight.